Company Analysis

Bicycle Therapeutics plc (BCYC)

Nasdaq: BCYC · Pharmaceutical Preparations · Cambridge, GB · filing with the SEC since 2018
Grade6.2
◀ Past 6.4● Present 5.8▶ Future 6.5
1 est.

Who runs Bicycle Therapeutics plc

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lee Kevin
CHIEF EXECUTIVE OFFICER. First filing May 2019, latest Oct 6, 2026, 30 filings in all.
Officers reporting now
7
of 21 people with a filing in the last fifteen months
Directors reporting now
14
37 people on the record since 2019
Officerssales are open-market, Oct 7, 2025 to Oct 7, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Perry Jennifer ScottChief Operating OfficerMar 2026Oct 7, 202611 · $0.00
Lee KevinCHIEF EXECUTIVE OFFICERMay 2019Oct 6, 20268 · $200,000
Thompson Travis AlvinChief Financial OfficerJul 2023Oct 6, 20268 · $0.00
Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFFMar 2024Oct 6, 20268 · $100,000
Skynner MichaelCHIEF SCIENTIFIC OFFICERMay 2019Oct 6, 20268 · $100,000
Young AlethiaChief Financial OfficerJul 2023Jan 6, 20263 · $100,000
Milnes AlistairCHIEF OPERATING OFFICERJan 2022Jan 6, 20262 · $0.00
Directorssales are open-market, Oct 7, 2025 to Oct 7, 2026
NameRoleFirst filingLatest filingSales, 12 months
Swanton Robert CharlesdirectorAug 2025Oct 6, 20261 · $0.00
667, L.P.directorApr 2024Jan 6, 2026none
Baker Bros. Advisors (Gp) LLCdirectorApr 2024Jan 6, 2026none
Baker Bros. Advisors LPdirectorApr 2024Jan 6, 2026none
Baker Brothers Life Sciences LPdirectorApr 2024Jan 6, 2026none
Baker FelixdirectorApr 2024Jan 6, 2026none
Baker JuliandirectorApr 2024Jan 6, 2026none
Bourque JanicedirectorJul 2019Jan 6, 2026none
Dansey Roger DdirectorSep 2025Jan 6, 2026none
Gutierrez-Ramos Jose-CarlosdirectorMar 2021Jan 6, 2026none
Hoppenot HervedirectorSep 2025Jan 6, 2026none
Riva AlessandrodirectorMar 2025Jan 6, 2026none
Sands Stephen H.directorFeb 2024Jan 6, 2026none
Winter Gregory PauldirectorMay 2019Jan 6, 2026none
Earlier names on the record29, newest filing first
Westin Eric · officer · last filing Mar 2025Arroyo Santiago · officer · last filing Jan 2025Crockett Nigel · officer · last filing Jan 2025Kender Richard N · director · last filing Jan 2025Legault Pierre · director · last filing Jan 2025Keen Nicholas · officer · last filing Jul 2024Jordan Veronica Gh · director · last filing Jan 2024Kalowski Lee · officer · last filing Apr 2023Smethurst Dominic · officer · last filing Jan 2023Bingham Kate · director · last filing Jul 2021Glaxosmithkline PLC · director · last filing Sep 2020Hau Bosun · director · last filing Jun 2019Aquila Investments IV · 10% owner · last filing Jun 2019Krishnan Viswanathan · 10% owner · last filing Jun 2019Tybourne Capital Management (Hk) Ltd · 10% owner · last filing Jun 2019Tybourne Capital Management Ltd · 10% owner · last filing Jun 2019Tybourne Kesari Ltd · 10% owner · last filing Jun 2019Ng Carolyn · director · last filing May 2019Cambridge Innovation Capital (Jersey) Ltd · 10% owner · last filing May 2019Leone Peter Brian · officer · last filing May 2019Anstey Michael · director · last filing May 2019Harland Deborah · director · last filing May 2019Novartis AG · 10% owner · last filing May 2019Novartis Bioventures Ltd · 10% owner · last filing May 2019Sv Life Sciences Fund V (Gp), LP · 10% owner · last filing May 2019Sv Life Sciences Fund V LP · 10% owner · last filing May 2019Sv Life Sciences Fund V Strategic Partners, L.P. · 10% owner · last filing May 2019Svlsf V, LLC · 10% owner · last filing May 2019Vertex Global Healthcare Fund I Pte Ltd. · 10% owner · last filing May 2019

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton BCYC · research, not advice